AI-Associatied Musculoskeletal Symptoms
Conditions
Interventions
experimental group :Jintiange and Caltrate D
control grouop:Caltrate D
Sponsors
Guanganmen Hospital, China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. women who are diagnosed with breast cancer stage 0-III without Recurrence metastasis; 2. women who in postmenopaul women including ovarian sression true postmenopause; 3. women who planed to initating AI therapy within two weeks or have taken on more than one week; 4. The ECOG Scroe is 0-2.5; 5. people who sign the Informed consent.
Exclusion criteria
Exclusion criteria: 1. Endocrine other diseases affecting bone metabolism(Hyperthyroidism, JiaJian, diabetes, chronic liver disease syndrome, kidney disease, multiple myeloma, hin, bone metastases, etc; 2. use Bone metabolism, painkillers antidepresnts nearly a month(Ammonia, thyroxine, double sugar phosphate, non-steroidal antipyretic analgesics, antidepresnts, etc; 3. Use Chinese traditional medicine that has the fundtion of kidney strong bone painkillers nearly a month; 4. A history of temic arthritis; 5. Serious heart disease, liver disease, kidney disease; 6. Pregnant women, mental disorders, cognitive dysfunction.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS2;FACT-B3;BPI-SF (modified); | — |
Secondary
| Measure | Time frame |
|---|---|
| E2 FSH; | — |
Countries
China
Contacts
Public ContactWenLu
Outcome results
None listed